Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50%
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50%" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include WSJ, BioSpace, Yahoo Finance and Fierce Biotech. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 39m ago.
Quick answers
Why is "Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50%" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- Genmab Shares Soar on Success in Head and Neck Cancer WSJ · 8h ago
- Genmab’s cancer bispecific delivers early survival win in ‘exceedingly positive’ Phase 3 readout BioSpace · 8h ago
- GMAB Stock Hits All-Time High After Genmab’s Cancer Drug Trial Meets Primary Goals Yahoo Finance · 8h ago
- Genmab's $8B Merus bet delivers as bispecific combo halves risk of death in phase 3 Fierce Biotech · 8h ago
- Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50% Barron's · 8h ago
Topics
Related trends
Navy Sees 10-year High For Class A Aviation, Afloat Mishaps
4 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
China's Stock Market Has Lost $2.4 Trillion as Investors Doubt Its AI Boom Will Ever Pay Off
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Seagate Stock Slides Despite Earnings Beat, Adding To Slump For AI Stock
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Stock Market Today: Dow stays flat, Nasdaq and S&P 500 surge as oil prices fall and chip stocks bounce
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Boeing Stock Plunges After Earnings. 737 Progress Is Not Fast Enough.
Boeing shares plummeted over 11% following a cautious growth forecast and delays in 737 production targets that push ramp-ups into 2027.
Micron Stock Finds Its Footing as It Pushes Back on Chinese Memory Threat
Micron stock is seeing positive movement amid shifting analyst sentiment and broader gains in the memory sector.